How Medical Cannabis Fits the French Care Pathway (EN)

France’s healthcare model is one of the most structured in Europe, with clearly defined patient journeys and strong expectations around evidence, follow up, and coordination. As the national rollout begins, the challenge will be to design a pathway that feels familiar to clinicians and pharmacists while also accommodating a new therapeutic category.

This panel maps how medical cannabis can be integrated into the French care pathway. It follows the progression from specialist referral to GP involvement to pharmacy dispensing, examining where education, digital tools, and workflow adjustments are needed to maintain quality and continuity of care.